Gene Patent Case Fuels U.S. Court Test of Stem Cell Right
<div class="clearfix" id="story_content">
<p>As scientists get closer to using embryonic stem cells in new treatments for blindness, spinal cord injuries and heart disease, a U.S. legal debate could determine who profits from that research.</p>
